BFA
IMUX icon

BlackRock Fund Advisors’s Immunic IMUX Stock Holding History

BlackRock Fund Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.3M Sell
1,898
-817
-30% -$1.79M ﹤0.01% 3058
2016
Q3 		$6.65M Buy
2,715
+180
+7% +$444K ﹤0.01% 2701
2016
Q2 		$6.29M Buy
2,535
+172
+7% +$565K ﹤0.01% 2669
2016
Q1 		$8.57M Buy
2,363
+48
+2% +$167K ﹤0.01% 2450
2015
Q4 		$10.7M Buy
2,315
+1,226
+113% +$4M ﹤0.01% 2407
2015
Q3 		$1.76M Sell
1,089
-19
-2% -$95.1K ﹤0.01% 3143
2015
Q2 		$9.35M Buy
1,108
+702
+173% +$6.7M ﹤0.01% 2544
2015
Q1 		$4.06M Buy
406
+11
+3% +$101K ﹤0.01% 2937
2014
Q4 		$3.94M Buy
395
+89
+29% +$685K ﹤0.01% 2996
2014
Q3 		$2.5M Sell
306
-12
-4% -$113K ﹤0.01% 3083
2014
Q2 		$3.47M Buy
+318
New +$2.23M ﹤0.01% 3024

Other funds holding IMUX

Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

BlackRock Fund Advisors's IMUX Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Immunic (IMUX) stake by 30% in Q4 2016, selling an estimated $1.79M and leaving 1,898 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3058.

BlackRock Fund Advisors first reported a position in IMUX in Q2 2014 and has held it in 11 quarters since. The position peaked at $10.7M in Q4 2015. 55 funds tracked by Wall St. Rank hold IMUX as of Q4 2016.

  • BlackRock Fund Advisors held 1,898 shares of Immunic worth $3.3M as of Q4 2016.
  • BlackRock Fund Advisors sold 817 Immunic shares in Q4 2016, an estimated $1.79M.
  • Immunic made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3058 holding.
  • BlackRock Fund Advisors first reported a position in Immunic in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Fund Advisors's Immunic position peaked at $10.7M in Q4 2015.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.